These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6969740)

  • 1. In vitro differentiation of two surface markers for immature T cells by the synthetic pentapeptide, thymopoietin.
    Nash L; Good RA; Hatzfeld A; Goldstein G; Incefy GS
    J Immunol; 1981 Jan; 126(1):150-3. PubMed ID: 6969740
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoregulation by thymopoietin.
    Goldstein G; Lau CY
    J Supramol Struct; 1980; 14(3):397-403. PubMed ID: 6971374
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of thymopoietin pentapeptide (TP5) on autoimmunity. I. TP5 suppression of induced erythrocyte autoantibodies in C3H mice.
    Lau CY; Freestone JA; Goldstein G
    J Immunol; 1980 Oct; 125(4):1634-8. PubMed ID: 6967912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levamisole on autologous rosette-forming cells in nude mice.
    Van Wauwe J; Van Nijen G
    Clin Exp Immunol; 1977 Dec; 30(3):465-8. PubMed ID: 304789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional maturation difference between splenocytes that form autologous rosettes in adult thymectomized and aged mice.
    Yamanaka R; Good RA; Incefy GS
    Thymus; 1983; 5(1):35-42. PubMed ID: 6302958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    Thymus; 1980 Jan; 1(4-5):195-204. PubMed ID: 7445020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L; Szende B; Hajós G; Szporny L; Lapis K
    Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.
    Goldstein G; Scheid MP; Boyse EA; Schlesinger DH; Van Wauwe J
    Science; 1979 Jun; 204(4399):1309-10. PubMed ID: 451537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to thymopoietin following implantation of paper disks derivatized with synthetic Cys-thymopoietin.
    Viamontes GI; Audhya T; Goldstein G
    J Immunol Methods; 1986 Nov; 94(1-2):13-7. PubMed ID: 3782805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic hormones and immunopeptides.
    Khan A
    Ann Allergy; 1978 Aug; 41(2):78-83. PubMed ID: 308333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structural similarity and functional activity of molecular fragments of staphylococcal enterotoxin B and thymopoietin II].
    Vegner RE; Rituma IR; Chipens GI; Duplishcheva AP; Mysiakin EB
    Bioorg Khim; 1987 Jan; 13(1):122-4. PubMed ID: 3566816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase in the content of thymus hormone sensitive rosette-forming cell precursors in the spleen of mice vaccinated against smallpox].
    Trubcheninova LP; Radzikhovskaia RM; Bukhman VM; Chimishkian KL; Svet-Moldavskiĭ GIa
    Biull Eksp Biol Med; 1978 Oct; 86(10):458-9. PubMed ID: 708876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential lysis of undifferentiated thymocytes by natural thymocytotoxic antibodies from New Zealand black mice.
    Huston DP; Raveche ES; Steinberg AD
    J Immunol; 1980 Apr; 124(4):1635-41. PubMed ID: 6988504
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical localization of thymopoietin with an antiserum to synthetic Cys-thymopoietin28-39.
    Viamontes GI; Audhya T; Goldstein G
    Cell Immunol; 1986 Jul; 100(2):305-13. PubMed ID: 2428508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

  • 18. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.
    Jackson TM; Zaman SN
    Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peanut agglutinin. V. Thymocyte subpopulations in the mouse studied with peanut agglutinin and Ly-6.2 antiserum.
    London J; Horton MA
    J Immunol; 1980 Apr; 124(4):1803-7. PubMed ID: 6988508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.